Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière, INSERM UMR_S975, CNRS UMR7225, Université Pierre et Marie Curie-Paris 6, Hôpital Pitié-Salpêtrière, Paris, France.
Neurobiol Aging. 2013 Jun;34(6):1709.e1-2. doi: 10.1016/j.neurobiolaging.2012.10.026. Epub 2012 Nov 24.
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are 2 adult onset neurological disorders with overlapping symptoms and clinical characteristics. It is well established that they share a common pathologic and genetic background. Recently, mutations in profilin 1 gene (PFN1) have been identified in patients with familial ALS, suggesting a role for this gene in the pathogenesis of the disease. Based on this, we hypothesized that mutations in PFN1 might also contribute to FTLD disease. We studied a French cohort of 165 ALS/FTLD patients, without finding any variant. We conclude that mutations in PFN1 are not a common cause for ALS/FTLD in France.
肌萎缩侧索硬化症(ALS)和额颞叶变性(FTLD)是两种成人发病的神经退行性疾病,具有重叠的症状和临床特征。它们具有共同的病理和遗传背景,这一点已经得到充分证实。最近,在家族性 ALS 患者中发现了原肌球蛋白 1 基因(PFN1)的突变,提示该基因在疾病发病机制中起作用。基于此,我们假设 PFN1 突变也可能导致 FTLD 疾病。我们研究了一个由 165 名 ALS/FTLD 患者组成的法国队列,没有发现任何变异。我们的结论是,PFN1 突变不是法国 ALS/FTLD 的常见病因。